Exact Mass: 499.0505434

Exact Mass Matches: 499.0505434

Found 17 metabolites which its exact mass value is equals to given mass value 499.0505434, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

VX-11e

4-{2-[(2-Chloro-4-Fluorophenyl)amino]-5-Methylpyrimidin-4-Yl}-N-[(1s)-1-(3-Chlorophenyl)-2-Hydroxyethyl]-1h-Pyrrole-2-Carboxamide

C24H20Cl2FN5O2 (499.0978012)


VX-11e is a potent, selective, and orally bioavailable inhibitor of ERK with Ki < 2 nM.

   

3,4,5-Trimethoxybenzyl glucosinolate

3,4,5-Trimethoxybenzyl glucosinolate

C17H25NO12S2 (499.081813)


   

Antibiotic SF 1623

Antibiotic SF 1623

C15H21N3O10S3 (499.0389046)


   

3-[(4-Methyl-3,5-dinitrophenyl)sulfonyl]-2-(2,4,5-trimethoxypheny l)-1,3-thiazolidine

3-[(4-Methyl-3,5-dinitrophenyl)sulfonyl]-2-(2,4,5-trimethoxypheny l)-1,3-thiazolidine

C19H21N3O9S2 (499.07191760000006)


   

Benzyl {3-bromo-1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo[2,3-b]pyr idin-5-yl}carbamate

Benzyl {3-bromo-1-[(4-methylphenyl)sulfonyl]-1H-pyrrolo[2,3-b]pyr idin-5-yl}carbamate

C22H18BrN3O4S (499.02013280000006)


   

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-Hexanesulfonamide

N-[3-(dimethyloxidoamino)propyl]-1,1,2,2,3,3,4,4,5,5,6,6,6-tridecafluoro-1-Hexanesulfonamide

C11H12F13N2O3S- (499.0361018)


   

Satraplatin

Satraplatin

C10H22Cl2N2O4Pt (499.0604402)


   

Sodelglitazar

2-[4-[[2-[2-fluoro-4-(trifluoromethyl)phenyl]-4-methyl-1,3-thiazol-5-yl]methylsulfanyl]-2-methylphenoxy]-2-methylpropanoic acid

C23H21F4NO3S2 (499.0898924)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist

   

N,N-Terephthaloyldisulfanilic acid disodium salt

N,N-Terephthaloyldisulfanilic acid disodium salt

C20H16N2NaO8S2+ (499.0245756)


   

Azane;cyclohexanamine;platinum(4+);diacetate;dichloride

Azane;cyclohexanamine;platinum(4+);diacetate;dichloride

C10H22Cl2N2O4Pt (499.0604402)


   

(1R,2S,3R,4R,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl (1S,2R,3S,4S,5R,6R)-2,3,4,6-tetrahydroxy-5-(phosphonatooxy)cyclohexyl phosphate

(1R,2S,3R,4R,5S,6S)-2,3,4,5,6-pentahydroxycyclohexyl (1S,2R,3S,4S,5R,6R)-2,3,4,6-tetrahydroxy-5-(phosphonatooxy)cyclohexyl phosphate

C12H21O17P2-3 (499.0253976)


   

2-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxypropanoic acid

2-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxypropanoic acid

C13H19N5O12P2 (499.0505434)


   

[4-(2-Chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone

[4-(2-Chlorophenyl)sulfonyl-3-nitrophenyl]-[4-(phenylmethyl)-1-piperazinyl]methanone

C24H22ClN3O5S (499.0968632000001)


   

(R)-VX-11e

(R)-VX-11e

C24H20Cl2FN5O2 (499.0978012)


(R)-VX-11e (Compound 1) is an ERK2 inhibitor[1].

   

(7s)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-3-[(sulfosulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(7s)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-3-[(sulfosulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H21N3O10S3 (499.0389046)


   

[(e)-(1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(3,4,5-trimethoxyphenyl)ethylidene)amino]oxysulfonic acid

[(e)-(1-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl}-2-(3,4,5-trimethoxyphenyl)ethylidene)amino]oxysulfonic acid

C17H25NO12S2 (499.081813)


   

(6r,7s)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-3-[(sulfosulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

(6r,7s)-7-{[(5r)-5-amino-5-carboxy-1-hydroxypentylidene]amino}-7-methoxy-8-oxo-3-[(sulfosulfanyl)methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid

C15H21N3O10S3 (499.0389046)